We will address whether they are appropriate for your individual needs when we customize your treatment plan
Newer drugs, such as tirzepatide, a dual GLP-1, and GIP receptor agonist, are quickly gaining traction and demonstrating encouraging outcomes in clinical trials for weight management. Other popular diabetes medications include metformin, gliflozins (Farxiga, Jardiance), and sulfonylureas (Glucotrol, Amaryl)
Clinician-led GLP-1 weight-loss visits that review eligibility , insurance and pharmacy access, side effects , and ongoing follow-up across Nao Medical's NYC and Long Island clinic network
Appetite changes come first, followed by weight loss that tends to build as the dose increases over several months
Having them does not mean you injected incorrectly